MA45609A - Compositions d'acide cromoglicique pour le traitement de la dermatite - Google Patents

Compositions d'acide cromoglicique pour le traitement de la dermatite

Info

Publication number
MA45609A
MA45609A MA045609A MA45609A MA45609A MA 45609 A MA45609 A MA 45609A MA 045609 A MA045609 A MA 045609A MA 45609 A MA45609 A MA 45609A MA 45609 A MA45609 A MA 45609A
Authority
MA
Morocco
Prior art keywords
dermatitis
compositions
treatment
cromoglicic acid
cromoglicic
Prior art date
Application number
MA045609A
Other languages
English (en)
Other versions
MA45609B1 (fr
Inventor
Díaz Javier Alcover
Lorenzana Laura Fernández
Peláez Ricardo Palacios
De La Losa Fernando Pineda
Gil David Rodríguez
García José Ángel Sánchez
Ferrer Concepción Tiana
De La Torre Marta Vicario
Original Assignee
Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S A
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S A, Farmalider Sa filed Critical Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S A
Publication of MA45609A publication Critical patent/MA45609A/fr
Publication of MA45609B1 publication Critical patent/MA45609B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MA45609A 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite MA45609B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201630928A ES2653787B1 (es) 2016-07-07 2016-07-07 Composiciones de ácido cromoglícico para el tratamiento de la dermatitis
EP17830533.0A EP3482761B1 (fr) 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite
PCT/ES2017/070490 WO2018015593A1 (fr) 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite

Publications (2)

Publication Number Publication Date
MA45609A true MA45609A (fr) 2019-05-15
MA45609B1 MA45609B1 (fr) 2024-07-31

Family

ID=60992131

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45609A MA45609B1 (fr) 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite

Country Status (19)

Country Link
US (1) US20190240193A1 (fr)
EP (1) EP3482761B1 (fr)
CN (1) CN109715153A (fr)
DK (1) DK3482761T3 (fr)
ES (2) ES2653787B1 (fr)
FI (1) FI3482761T3 (fr)
HR (1) HRP20240775T1 (fr)
HU (1) HUE066913T2 (fr)
LT (1) LT3482761T (fr)
MA (1) MA45609B1 (fr)
MX (1) MX386042B (fr)
PL (1) PL3482761T3 (fr)
PT (1) PT3482761T (fr)
RS (1) RS65561B1 (fr)
RU (1) RU2754006C2 (fr)
SI (1) SI3482761T1 (fr)
SM (1) SMT202400230T1 (fr)
UA (1) UA130333C2 (fr)
WO (1) WO2018015593A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2587402B (en) * 2019-09-27 2023-05-10 Hewlett Healthcare Ltd Formulation
AU2022226676A1 (en) 2021-02-25 2023-09-28 Alphyn Biologics, Llc Composition for treatment of topical dermatological bacterial skin conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262108B1 (en) * 1997-12-03 2001-07-17 Kyoto Pharmaceutical Industries, Ltd. Medicinal use of cromoglycic acid compounds
BRPI0510906A (pt) * 2004-05-19 2007-11-06 Emisphere Tech Inc composição farmacêutica tópica, composição para administração tópica e seu uso
WO2008148572A1 (fr) * 2007-06-08 2008-12-11 Bayer Consumer Care Ag Combinaisons de principes actifs anti-inflammatoires pour le traitement de maladies de la peau et des muqueuses
RU2472499C2 (ru) * 2007-06-08 2013-01-20 Байер Конзюмер Кер АГ Лекарственное средство, включающее комбинацию активных веществ, содержащую пантотеновую кислоту или ее производные, для лечения аллергических симптомов
ES2353541B1 (es) * 2009-07-30 2011-09-20 Farmalider, S.A. Combinacion de ingredientes activos cosmeticos y composicion cosmetica obtenida a partir de la misma, y su utilizacion.
TR200907914A2 (tr) * 2009-10-20 2011-05-23 B�Lg�� Mahmut Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
IT1400386B1 (it) * 2010-05-27 2013-05-31 Roberto Logi Kit di parti per il trattamento e/o prevenzione delle ulcere cutanee

Also Published As

Publication number Publication date
UA130333C2 (uk) 2026-01-28
PT3482761T (pt) 2024-06-18
LT3482761T (lt) 2024-07-10
ES2653787A1 (es) 2018-02-08
RU2754006C2 (ru) 2021-08-25
ES2979376T3 (es) 2024-09-25
ES2653787B1 (es) 2018-09-25
SMT202400230T1 (it) 2024-07-09
EP3482761B1 (fr) 2024-04-24
RU2019103272A3 (fr) 2020-11-03
DK3482761T3 (da) 2024-05-27
MX386042B (es) 2025-03-18
WO2018015593A1 (fr) 2018-01-25
MA45609B1 (fr) 2024-07-31
EP3482761A4 (fr) 2020-03-11
HRP20240775T1 (hr) 2024-09-13
HUE066913T2 (hu) 2024-09-28
RS65561B1 (sr) 2024-06-28
RU2019103272A (ru) 2020-08-07
EP3482761A1 (fr) 2019-05-15
PL3482761T3 (pl) 2024-07-22
SI3482761T1 (sl) 2024-08-30
US20190240193A1 (en) 2019-08-08
FI3482761T3 (fi) 2024-06-03
MX2019000136A (es) 2019-10-21
CN109715153A (zh) 2019-05-03

Similar Documents

Publication Publication Date Title
FR25C1001I2 (fr) Compositions d'anticorps pour le traitement de tumeurs
MA47719A (fr) Esketamine pour le traitement de la dépression
MA45539A (fr) Dihydropyranopyrimidines pour le traitement d'infections virales
EP3491149A4 (fr) Traitement d'acide nucléique indépendant
EP3448875A4 (fr) Compositions pour le traitement de maladies
EP3448987A4 (fr) Compositions pour le traitement de maladies
MA44875A (fr) Compositions pour le traitement de troubles acido-basiques
MA44083A (fr) Composés de biarylmonobactame pour le traitement d'infections bactériennes
MA49628A (fr) Processus pour la purification de l'acide hyaluronique
MA44737A (fr) Compositions pour le traitement de troubles liés à l'hyperkératose
EP3541408A4 (fr) Compositions et méthodes pour le traitement de l'angiogenèse aberrante
EP3352749A4 (fr) Composés et compositions pour le traitement de troubles oculaires
EP3541379A4 (fr) Compositions pour le traitement de l'hypertension
EP3458079A4 (fr) Compositions et méthodes pour le traitement de l'acné
EP3344325A4 (fr) Administration locale de médicaments pour le traitement de l'asthme
EP3716966A4 (fr) Compositions d'alpha-cétoacides pour le traitement de l'hypoalbuminémie
MA42985A (fr) Traitement de troubles liés à l'acide biliaire
EP3538219A4 (fr) Compositions topiques destinées au traitement de l'acné
MA43230A (fr) Méthodes et compositions pour le traitement d'une épidermolyse bulleuse
EP3522865A4 (fr) Méthodes et compositions pour le traitement de vergetures
EP3368048A4 (fr) Méthodes et compositions pour le traitement de l'amyloïdose
MA45552A (fr) Compositions destinées au traitement de l'amylose
EP3344650A4 (fr) Aav-epo pour le traitement d'animaux de compagnie
EP3453046A4 (fr) Composés glutarate pour le traitement de lésions d'ischémie-reperfusion
EP3506927A4 (fr) Compositions de reeline pour le traitement des troubles neurologiques